Blood Cancer Patients See Greater Success Rate When Adding Cannabis
A 2017 study finds that cannabinoid therapy, after chemotherapy, significantly improved outcomes for blood cancer patients.
We’ve all heard the personal accounts of cannabis fighting against different kinds of cancers. Additionally, studies have demonstrated it to effectively reduce tumor size, stimulate appetite, and ease pain — all great effects for patients with malignant tumors. But, do the same benefits hold true for blood cancer?
Patients consuming cannabis to target cancer, or cancer-related symptoms, say it’s a big help. And every year, more and more blood cancer patients take medical cannabis to help manage and treat their diseases.
Does the science back up the testimony? And are the patients actually treating the cancer itself? Or are they just managing the unpleasant side effects of the cancer, or even the side effects of cancer treatments like chemotherapy? Recent studies shed light on how cannabis contributes to the fight against blood cancer.
Blood Cancer is Common and Deadly
When most people think “cancer,” they picture organ cancers: skin cancer, lung cancer, pancreatic, liver, etc. But while blood cancers may not be spoken about as much in main stream media, these are very common — and very deadly.
Strictly speaking, blood cancer is a growth of malignant cells that affect the production and function of blood cells. The bone marrow tends to be the source of the disease, as this is where blood cells are made.
According to the American Society of Hematology, there are three main types of blood cancers: leukemia, which is found in the blood and bones; lymphoma, which affects the lymphatic system; and myeloma, which is concentrated in the plasma cells.
Approximately 175,000 people in the United States are diagnosed with blood cancer each year. More than 1.3 million Americans are living with one of the three main types of blood cancer. And someone in America dies from a blood cancer-related illness every nine minutes; that’s about 160 people every single day.
In other words, blood cancer is bad. It goes without saying that blood is crucial part for your body’s circuitry. It’s delivers nutrients throughout your body and is responsible for gas exchange. It’s the stuff of life; when it fails, the whole body suffers.
How Successful is Cannabis in Stopping Leukemia?
There are more than 11 kinds of leukemia, which the most common category of blood cancer. And approximately 170,000 people in the United States are diagnosed with leukemia annually.
In 2017, scientists discovered that both CBD and THC effectively kill leukemia cells. But, interestingly, the best results were seen when cannabis-based treatment came after chemotherapy.
Essentially, the specific combination of cannabis treatment following chemotherapy greatly improved outcomes. This was much more effective than either treatment on its own. When scientists tried to reverse the order of the treatments, and start with cannabis, fewer leukemia cells succumbed to cell death. Further studies will investigate the mechanisms behind these results.
More specifically, the paper found that CBD was essential in encouraging apoptosis (cell death) in the leukemia cells. As well, both CBD and THC directly disrupt the life cycle of leukemia cells, also leading to cell death. All healthy blood cells were unscathed.
The study results gave good evidence that medical cannabis should be considered for leukemia patients, even while mechanisms are still under investigation. Cannabis looks like a win for blood cancer patients. Not only is it effective at helping cancer patients feel more vital by improving appetite and reducing pain, it’s also fighting to rid the blood of cancerous infiltrator
What About Cannabis for Other Blood Cancers?
A different study out of the Department of Microbiology and Immunology at Virginia Commonwealth University, and published in the journal Blood, found that THC treatment causes cell death in lymphoma cells.
This study zeroed in on how cannabinoids react with the CB2 receptors in the body’s endocannabinoid system. Through demonstrations on lab rats, the study proved that certain THC-based blood cancer treatments cured 25% of cases. That’s huge for cancer patients.
And myeloma? As a rarer kind of cancer, and an especially nasty kind at that, myeloma research has been slower to develop. But several studies have shown that cannabinoids have anti-carcinogenic effects in patients suffering from this disease. It works against myeloma in much the same way as against lymphoma: by inducing cell death in cancerous cells.
The Last Word
Taken together, these studies show that cannabinoids and cannabinoid receptors play an important role in the immune system’s response to blood cancer. Not only can cannabis treat patients’ symptoms and improve their quality of life through better sleep, improved mood, and increased appetite, they can actually reduce the number of blood cancer cells in the body when combined with more traditional cancer treatments.
The world of oncology research needs to dig deeper into the role that cannabinoid therapy plays in treating cancer, but these sort of results bolster resolve and investment into studies. There is already solid scientific footing to suggest that cannabis-based drugs have an important role as an integral part of fight against blood cancer.